This watershed decision unleashes the full potential of the Apertum ecosystem, including its DAO1 DeFi platform and native $APTM token. Apertum is now poised for ...

NEW YORK, July 31, 2025 /PRNewswire/ -- Digital asset technology developer The Apertum Foundation and its senior advisor, Josip Heit, have prevailed in their litigation against the Texas State ...

NEW YORK, July 31, 2025 /PRNewswire/ -- Digital asset technology developer The Apertum Foundation and its senior advisor, Josip Heit, have prevailed in their litigation against the Texas State ...

ROMAN FURY is set to take to the ring in Hungary, as his brother Tommy Fury main events against Kenan Hanjalic. Tyson Fury's brother will return to in-ring action on the undercard of his other brother ...

Union Berlin have agreed a deal with Celtic worth up to £10m to sign right-back Josip Juranovic. The initial fee is understood to be £7.5m plus add-ons and the Croatian has been given permission to ...

Croatian Deputy Prime Minister Josip Dabro resigned on Saturday after a video of him shooting a gun out of a moving car surfaced in local media. Dabro, who also was agriculture minister, on Friday ...

Today (Thursday) the icon of popular music, Ismet Bogujevci, passed away. This was announced by his son confirming the news in a post published on social networks. The Ministry of Culture, Tourism and ...

In the 24-hour report, the Kosovo Police announced that it was reported to law enforcement that two unknown persons poured gasoline and tried to set fire to the school. The case happened on Friday at ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Josip Stanišić has committed his future to Bayern Munich, the Croatia international signing a contract extension through to 30 June 2029. "We're happy that Josip has signed a long-term contract ...

Descriptive analyses; median follow-up 33.8 mo. NR, not reached. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.

A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna. Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and ...